Daily Derm Times: May 6, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Supporting Patients With Rare Genetic Skin Diseases and the Foundations Dedicated to Them

In his May letter, Christopher Bunick, MD, PhD, reflects on his journey as a physician-scientist and advocates for supporting foundations dedicated to rare skin diseases.

MJH Life Sciences Expands Beauty and Aesthetics Scope With NewBeauty

MJH Life Sciences acquires NewBeauty, merging clinical expertise with consumer-driven wellness to redefine beauty and aesthetics media.

Clinical Trial Validates Delgocitinib’s HRQoL Benefits

Delgocitinib cream significantly enhances health-related quality of life for patients with chronic hand eczema, addressing both symptoms and psychosocial impacts.

Upadacitinib Shows Promise in Reducing Cardiovascular and Thrombotic Risks in Atopic Dermatitis Patients

Researchers reported that upadacitinib may lower the incidence of major cardiovascular events and venous thromboembolism in AD.

Nail Care’s Hidden Health Costs

Explore the hidden health risks of nail products and the urgent need for safety reforms in the nail salon industry for workers and customers alike.

Topical Steroid Withdrawal: Uncovering Neuroinflammatory Mechanisms

Our May cover story explores NIH’s new findings on topical steroid withdrawal, a condition now under scientific scrutiny as a distinct entity.